• Advertise
  • Privacy & Policy
  • Contact
Wednesday, June 18, 2025
itida
Egyptian Gazette

Editor-in-Chief

Mohamed Fahmy

Board Chairman

Tarek Lotfy

  • HOME
  • EGYPT
    • Local
    • Features
  • World
    • National Day
  • Technology
  • BUSINESS
    • Real Estate
    • Automotive
  • SPORTS
  • ENTERTAINMENT
    • Arts
    • Health
    • Lifestyle
    • Travel
  • Skyward
    • Flight schedules
    • EgyptAir booking
    • Snippets from EgyptAir history
    • EgyptAir history
    • Your Shipment On Time
    • Discover the World of Shopping
  • MORE
    • Multimedia
      • Video
      • Podcast
      • Gallery
    • OP-ED
No Result
View All Result
  • HOME
  • EGYPT
    • Local
    • Features
  • World
    • National Day
  • Technology
  • BUSINESS
    • Real Estate
    • Automotive
  • SPORTS
  • ENTERTAINMENT
    • Arts
    • Health
    • Lifestyle
    • Travel
  • Skyward
    • Flight schedules
    • EgyptAir booking
    • Snippets from EgyptAir history
    • EgyptAir history
    • Your Shipment On Time
    • Discover the World of Shopping
  • MORE
    • Multimedia
      • Video
      • Podcast
      • Gallery
    • OP-ED
No Result
View All Result
Egyptian Gazette
No Result
View All Result
Home Entertainment Health

Britain begins world’s largest trial of blood test for 50 types of cancer

by News Wires
September 13, 2021
in Health
Britain begins world's largest trial of blood test for 50 types of cancer 1 - Egyptian Gazette
Share on FacebookWhatsapp

LONDON – Britain’s state-run National Health Service will on Monday begin the world’s biggest trial of Grail Inc’s (GRAL.O) flagship Galleri blood test that can be used to detect more than 50 types of cancer before symptoms appear, according Reuters.

The Galleri test looks at the DNA in a patient’s blood to determine if any come from cancer cells. Earlier diagnosis of cancers leads to dramatically increased survival rates.

The NHS said it wanted to recruit 140,000 volunteers in England to see how well the test worked as part of a randomised control trial. Half of the participants will have their blood sample screened with the Galleri test right away.

“We need to study the Galleri test carefully to find out whether it can significantly reduce the number of cancers diagnosed at a late stage,” said Peter Sasieni, professor of cancer prevention at King’s College London.

“The test could be a game changer for early cancer detection and we are excited to be leading this important research.”

Lung cancer is by far the most common cause of cancer death in the United Kingdom, accounting for around a fifth of all cancer deaths. Lung, bowel, prostate and breast cancers account for 45 per cent of the United Kingdom’s cancer deaths, the NHS said.

US life sciences company Illumina Inc (ILMN.O) said last month it had completed its $7.1 billion acquisition of Grail. Illumina said it will operate Grail separately from its existing business.

Tags: Blood testBritainCancer

Discussion about this post

egyptian-gazette-logo

The Egyptian Gazette is the oldest English-language daily newspaper in the Middle East.
It was first published on January 26, 1880 and it is part of El Tahrir Printing and Publishing House.

Follow Us

Gazette Notifications

Would you like to receive notifications on our latest news ?

  • Advertise
  • Privacy & Policy
  • Contact

Copyrights for © Egyptian Gazette - Administered by Digital Transformation Management.

No Result
View All Result
  • HOME
  • EGYPT
    • Local
    • Features
  • World
    • National Day
  • Technology
  • BUSINESS
    • Real Estate
    • Automotive
  • SPORTS
  • ENTERTAINMENT
    • Arts
    • Health
    • Lifestyle
    • Travel
  • Skyward
    • Flight schedules
    • EgyptAir booking
    • Snippets from EgyptAir history
    • EgyptAir history
    • Your Shipment On Time
    • Discover the World of Shopping
  • MORE
    • Multimedia
      • Video
      • Podcast
      • Gallery
    • OP-ED

Copyrights for © Egyptian Gazette - Administered by Digital Transformation Management.

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.